EM-T3Pharmacoepidemiology and Drug Safety2018-09-25第 27 卷第 11 期，1265-1276
The association between concerns toward adverse reactions during pre‐approval drug reviews and the post‐approval addition of clinically significant adverse reactions to package inserts: A retrospective analysis of pre‐approval drug review reports and safety updates
